Kristen Hege, Member Board of Directors at KSQ Therapeutics, Inc., shared a post on LinkedIn:
“I am excited to announce I will be presenting at the upcoming Society for Immunotherapy of Cancer’s Spring Scientific – Next-gen Cell Therapies, T cell Engagers, and Combinations – in Tucson and Virtual on March 25–27.
I would like to personally invite you to register to attend for the in-person or virtual event.
SITC has put together an incredible line-up of presentations from academia, industry, and government representatives. The Keynote will be given by Kristen M. Hege – “CAR-T Lessons Learned Guiding Next Gen Cell Therapies”.
I am also excited to announce we will have more than 100 abstract posters and a number of exhibitors showcasing their latest IO research, products and services.
I hope you can register today to hear about my presentation along with the other esteemed faculty.”
Other articles featuring Kristen Hege.